,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1295164,445070,Drug Gene Interaction database (DGIdb),"trans,trans-Farnesol",,FARNESOL,https://www.dgidb.org/drugs/FARNESOL,,MVK,https://www.dgidb.org/genes/MVK,,,4598.0,MVK,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1,1368941,445070,Therapeutic Target Database (TTD),"trans,trans-Farnesol",D0M0CF,Farnesol,https://idrblab.net/ttd/data/drug/details/D0M0CF,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2,1940978,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,30,ACAA1,https://ctdbase.org/detail.go?type=gene&acc=30,,,30.0,ACAA1,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACAA1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
3,1940979,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,10449,ACAA2,https://ctdbase.org/detail.go?type=gene&acc=10449,,,10449.0,ACAA2,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of ACAA2 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of ACAA2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
4,1940980,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACADM mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
5,1940981,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,35,ACADS,https://ctdbase.org/detail.go?type=gene&acc=35,,,35.0,ACADS,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACADS mrna|farnesol analog results in increased expression of ACADS mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
6,1940982,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,38,ACAT1,https://ctdbase.org/detail.go?type=gene&acc=38,,,38.0,ACAT1,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of ACAT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
7,1940983,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,39,ACAT2,https://ctdbase.org/detail.go?type=gene&acc=39,,,39.0,ACAT2,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of ACAT2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
8,1940984,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,641371,ACOT1,https://ctdbase.org/detail.go?type=gene&acc=641371,,,641371.0,ACOT1,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACOT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
9,1940985,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,134526,ACOT12,https://ctdbase.org/detail.go?type=gene&acc=134526,,,134526.0,ACOT12,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACOT12 mrna|farnesol analog results in increased expression of ACOT12 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
10,1940986,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,641372,ACOT6,https://ctdbase.org/detail.go?type=gene&acc=641372,,,641372.0,ACOT6,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of ACOT6 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
11,1941016,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51.0,ACOX1,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACOX1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
12,1941017,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,8309,ACOX2,https://ctdbase.org/detail.go?type=gene&acc=8309,,,8309.0,ACOX2,9606.0,Homo sapiens (human),Farnesol analog results in decreased expression of ACOX2 mrna|farnesol analog results in increased expression of ACOX2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
13,1941018,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2182,ACSL4,https://ctdbase.org/detail.go?type=gene&acc=2182,,,2182.0,ACSL4,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACSL4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
14,1941019,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,51703,ACSL5,https://ctdbase.org/detail.go?type=gene&acc=51703,,,51703.0,ACSL5,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ACSL5 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
15,1941020,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,10554,AGPAT1,https://ctdbase.org/detail.go?type=gene&acc=10554,,,10554.0,AGPAT1,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of AGPAT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
16,1941021,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,9606.0,Homo sapiens (human),AKR1B10 protein results in increased chemical synthesis of farnesol,,,PMID:21187079,https://www.ncbi.nlm.nih.gov/pubmed/21187079,21187079,,
17,1941022,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),Farnesol results in increased expression of AKR1C1 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
18,1941023,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606.0,Homo sapiens (human),AKR1C3 protein results in increased chemical synthesis of farnesol|[flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased metabolism of farnesol|[tolfenamic acid results in decreased activity of AKR1C3 protein] which results in increased metabolism of farnesol,,,PMID:21187079,https://www.ncbi.nlm.nih.gov/pubmed/21187079,21187079,,
19,1941024,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,116519,APOA5,https://ctdbase.org/detail.go?type=gene&acc=116519,,,116519.0,APOA5,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of APOA5 mrna|farnesol analog results in increased expression of APOA5 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
20,1941025,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,346,APOC4,https://ctdbase.org/detail.go?type=gene&acc=346,,,346.0,APOC4,9606.0,Homo sapiens (human),Farnesol analog results in decreased expression of APOC4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
21,1941061,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Farnesol results in increased expression of ATF3 mRNA,,,PMID:27965148,https://www.ncbi.nlm.nih.gov/pubmed/27965148,27965148,,
22,1941062,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606.0,Homo sapiens (human),Farnesol results in increased expression of BAK1 protein,,,PMID:12530055,https://www.ncbi.nlm.nih.gov/pubmed/12530055,12530055,,
23,1941063,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Farnesol results in increased activity of CASP3 protein,,,PMID:10733934,https://www.ncbi.nlm.nih.gov/pubmed/10733934,10733934,,
24,1941064,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Farnesol results in decreased activity of CASP3 protein,,,PMID:21453689,https://www.ncbi.nlm.nih.gov/pubmed/21453689,21453689,,
25,1941065,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Farnesol inhibits the reaction [tobacco smoke pollution results in decreased activity of CAT protein],,,PMID:18793622,https://www.ncbi.nlm.nih.gov/pubmed/18793622,18793622,,
26,1941066,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased expression of CAT protein,,,PMID:21453689,https://www.ncbi.nlm.nih.gov/pubmed/21453689,21453689,,
27,1941067,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,6351,CCL4,https://ctdbase.org/detail.go?type=gene&acc=6351,,,6351.0,CCL4,9606.0,Homo sapiens (human),Farnesol results in increased secretion of CCL4 protein,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
28,1941068,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,9606.0,Homo sapiens (human),Farnesol results in decreased expression of CCNA2 protein,,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
29,1941069,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606.0,Homo sapiens (human),Farnesol results in decreased expression of CCNB1 protein,,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
30,1941070,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),Farnesol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein]|farnesol results in decreased expression of CDK2 protein|farnesol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein],,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
31,1941071,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),CDKN1A protein results in increased susceptibility to farnesol|farnesol results in increased expression of CDKN1A protein|farnesol promotes the reaction [CDKN1A protein binds to and results in decreased activity of CDK2 protein],,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
32,1941072,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),Farnesol results in increased expression of CDKN1B protein|cdkn1b protein results in increased susceptibility to farnesol|farnesol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein],,,PMID:17138864,https://www.ncbi.nlm.nih.gov/pubmed/17138864,17138864,,
33,1941073,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1352,COX10,https://ctdbase.org/detail.go?type=gene&acc=1352,,,1352.0,COX10,9606.0,Homo sapiens (human),Farnesol analog results in decreased expression of COX10 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
34,1941074,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of CPT1A mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
35,1941075,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Farnesol results in increased expression of CXCL8 mRNA,,,PMID:27965148|PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/27965148|https://www.ncbi.nlm.nih.gov/pubmed/30806763,27965148|30806763,,
36,1941076,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Farnesol results in increased secretion of CXCL8 protein,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
37,1941077,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP19A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
38,1941078,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Farnesol results in increased expression of CYP1A1 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
39,1941079,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP1A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
40,1941080,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),Farnesol analog inhibits the reaction [oleic acid results in decreased expression of CYP1A2 mrna],,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
41,1941081,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP1A2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
42,1941122,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,57404,CYP20A1,https://ctdbase.org/detail.go?type=gene&acc=57404,,,57404.0,CYP20A1,7955.0,Danio rerio (zebrafish),Farnesol results in increased expression of CYP20A1 mRNA,,,PMID:26853319,https://www.ncbi.nlm.nih.gov/pubmed/26853319,26853319,,
43,1941123,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24894,CYP2A1,https://ctdbase.org/detail.go?type=gene&acc=24894,,,24894.0,Cyp2a1,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
44,1941124,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24895,CYP2A2,https://ctdbase.org/detail.go?type=gene&acc=24895,,,24895.0,Cyp2a2,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2A2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
45,1941125,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24299,CYP2A3,https://ctdbase.org/detail.go?type=gene&acc=24299,,,24299.0,Cyp2a3,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2A3 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
46,1941126,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24300,CYP2B1,https://ctdbase.org/detail.go?type=gene&acc=24300,,,24300.0,Cyp2b1,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2B1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
47,1941127,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,361523,CYP2B2,https://ctdbase.org/detail.go?type=gene&acc=361523,,,361523.0,Cyp2b2,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2B2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
48,1941128,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606.0,Homo sapiens (human),Farnesol analog inhibits the reaction [oleic acid results in decreased expression of CYP2B6 mrna]|farnesol results in increased expression of CYP2B6 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of CYP2B6 mrna|farnesol analog results in increased expression of CYP2B6 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
49,1941129,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,100328933,CYP2C,https://ctdbase.org/detail.go?type=gene&acc=100328933,,,100328933.0,CYP2C,9606.0,Homo sapiens (human),Farnesol results in increased expression of CYP2C mRNA,,,PMID:15629189,https://www.ncbi.nlm.nih.gov/pubmed/15629189,15629189,,
50,1941130,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,29277,CYP2C11,https://ctdbase.org/detail.go?type=gene&acc=29277,,,29277.0,Cyp2c11,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2C11 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
51,1941131,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,25011,CYP2C12,https://ctdbase.org/detail.go?type=gene&acc=25011,,,25011.0,Cyp2c12,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2C12 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
52,1941172,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of CYP2E1 mrna|farnesol analog inhibits the reaction [oleic acid results in increased expression of CYP2E1 mrna]|farnesol results in decreased expression of CYP2E1 mrna|farnesol analog results in decreased expression of CYP2E1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
53,1941173,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP2E1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
54,1941174,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682.0,Cyp3a2,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP3A2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
55,1941175,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642.0,Cyp3a23-3a1,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP3A23-3A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
56,1941176,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319.0,SCD,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of SCD mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
57,1941177,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Farnesol analog inhibits the reaction [oleic acid results in decreased expression of CYP3A4 mrna]|farnesol results in increased expression of CYP3A4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
58,1941178,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,50549,CYP4A1,https://ctdbase.org/detail.go?type=gene&acc=50549,,,50549.0,Cyp4a1,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP4A1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
59,1941179,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,24306,CYP4A2,https://ctdbase.org/detail.go?type=gene&acc=24306,,,24306.0,Cyp4a2,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP4A2 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
60,1941180,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,298423,CYP4A3,https://ctdbase.org/detail.go?type=gene&acc=298423,,,298423.0,Cyp4a3,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of CYP4A3 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
61,1941181,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1666,DECR1,https://ctdbase.org/detail.go?type=gene&acc=1666,,,1666.0,DECR1,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of DECR1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
62,1941231,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,8694,DGAT1,https://ctdbase.org/detail.go?type=gene&acc=8694,,,8694.0,DGAT1,9606.0,Homo sapiens (human),Farnesol analog results in decreased expression of DGAT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
63,1941232,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,84649,DGAT2,https://ctdbase.org/detail.go?type=gene&acc=84649,,,84649.0,DGAT2,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of DGAT2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
64,1941233,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,11080,DNAJB4,https://ctdbase.org/detail.go?type=gene&acc=11080,,,11080.0,DNAJB4,9606.0,Homo sapiens (human),Farnesol results in increased expression of DNAJB4 mRNA,,,PMID:27965148,https://www.ncbi.nlm.nih.gov/pubmed/27965148,27965148,,
65,1941234,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1891,ECH1,https://ctdbase.org/detail.go?type=gene&acc=1891,,,1891.0,ECH1,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of ECH1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
66,1941235,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606.0,Homo sapiens (human),Farnesol analog inhibits the reaction [EGF protein results in increased activity of RHOA protein]|farnesol analog results in decreased susceptibility to [INS protein co-treated with EGF protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
67,1941236,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of ELOVL6 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
68,1941237,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of FABP1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
69,1941238,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,9606.0,Homo sapiens (human),Farnesol results in increased expression of FABP4 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
70,1941239,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of FASN mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
71,1941240,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222.0,FDFT1,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of FDFT1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
72,1941241,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2339,FNTA,https://ctdbase.org/detail.go?type=gene&acc=2339,,,2339.0,FNTA,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of FNTA mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
73,1941295,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2342,FNTB,https://ctdbase.org/detail.go?type=gene&acc=2342,,,2342.0,FNTB,9606.0,Homo sapiens (human),Farnesol analog results in decreased expression of FNTB mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
74,1941296,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,137964,GPAT4,https://ctdbase.org/detail.go?type=gene&acc=137964,,,137964.0,GPAT4,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of GPAT4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
75,1941297,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of GSR protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
76,1941298,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased expression of GSR protein,,,PMID:21453689,https://www.ncbi.nlm.nih.gov/pubmed/21453689,21453689,,
77,1941299,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3030,HADHA,https://ctdbase.org/detail.go?type=gene&acc=3030,,,3030.0,HADHA,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of HADHA mrna|[farnesol analog co-treated with oleic acid] results in increased expression of HADHA mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
78,1941300,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3032,HADHB,https://ctdbase.org/detail.go?type=gene&acc=3032,,,3032.0,HADHB,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of HADHB mrna|farnesol analog results in increased expression of HADHB mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
79,1941301,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10029.0,Cricetulus griseus (Chinese hamster),Farnesol results in increased degradation of HMGCR protein,,,PMID:8021239,https://www.ncbi.nlm.nih.gov/pubmed/8021239,8021239,,
80,1941302,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of HMGCR mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
81,1941303,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),Farnesol results in decreased activity of HMGCR protein,,,PMID:12477733,https://www.ncbi.nlm.nih.gov/pubmed/12477733,12477733,,
82,1941304,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased expression of HMGCR protein,,,PMID:16332721,https://www.ncbi.nlm.nih.gov/pubmed/16332721,16332721,,
83,1941356,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Farnesol results in increased expression of HMOX1 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
84,1941357,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3265,HRAS,https://ctdbase.org/detail.go?type=gene&acc=3265,,,3265.0,HRAS,9606.0,Homo sapiens (human),Farnesol inhibits the reaction [simvastatin results in decreased farnesylation of and affects the localization of HRAS protein],,,PMID:12477733,https://www.ncbi.nlm.nih.gov/pubmed/12477733,12477733,,
85,1941358,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Farnesol results in increased expression of ICAM1 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
86,1941359,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3603,IL16,https://ctdbase.org/detail.go?type=gene&acc=3603,,,3603.0,IL16,9606.0,Homo sapiens (human),Farnesol results in increased secretion of IL16 protein,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
87,1941360,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606.0,Homo sapiens (human),Farnesol results in increased expression of IL1A mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
88,1941361,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Farnesol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to lipopolysaccharides] which results in increased expression of IL1B protein]|farnesol inhibits the reaction [[alendronate co-treated with lipopolysaccharides] results in increased expression of IL1B protein],,,PMID:20304105,https://www.ncbi.nlm.nih.gov/pubmed/20304105,20304105,,
89,1941362,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7850,IL1R2,https://ctdbase.org/detail.go?type=gene&acc=7850,,,7850.0,IL1R2,9606.0,Homo sapiens (human),Farnesol results in increased expression of IL1R2 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
90,1941363,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606.0,Homo sapiens (human),Farnesol analog results in decreased susceptibility to [INS protein co-treated with EGF protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
91,1941364,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,3990,LIPC,https://ctdbase.org/detail.go?type=gene&acc=3990,,,3990.0,LIPC,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of LIPC mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
92,1941365,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,23175,LPIN1,https://ctdbase.org/detail.go?type=gene&acc=23175,,,23175.0,LPIN1,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of LPIN1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
93,1941424,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,64900,LPIN3,https://ctdbase.org/detail.go?type=gene&acc=64900,,,64900.0,LPIN3,9606.0,Homo sapiens (human),Farnesol analog results in decreased expression of LPIN3 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
94,1941425,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,51085,MLXIPL,https://ctdbase.org/detail.go?type=gene&acc=51085,,,51085.0,MLXIPL,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of MLXIPL mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
95,1941426,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,4314,MMP3,https://ctdbase.org/detail.go?type=gene&acc=4314,,,4314.0,MMP3,9606.0,Homo sapiens (human),Farnesol results in increased expression of MMP3 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
96,1941427,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,9606.0,Homo sapiens (human),Farnesol inhibits the reaction [[MVK gene mutant form results in increased susceptibility to lipopolysaccharides] which results in increased expression of IL1B protein]|farnesol inhibits the reaction [MVK gene mutant form results in increased susceptibility to lipopolysaccharides],,,PMID:20304105,https://www.ncbi.nlm.nih.gov/pubmed/20304105,20304105,,
97,1941428,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,9606.0,Homo sapiens (human),Farnesol inhibits the reaction [MVK protein results in increased hydrolysis of adenosine triphosphate]|farnesol inhibits the reaction [MVK protein results in increased phosphorylation of mevalonic acid]|farnesol results in decreased activity of MVK protein,,,PMID:9392419,https://www.ncbi.nlm.nih.gov/pubmed/9392419,9392419,,
98,1941429,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,10398,MYL9,https://ctdbase.org/detail.go?type=gene&acc=10398,,,10398.0,MYL9,9606.0,Homo sapiens (human),Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MYL9 protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
99,1941430,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),Farnesol results in increased activity of NQO1 protein,,,PMID:15840382,https://www.ncbi.nlm.nih.gov/pubmed/15840382,15840382,,
100,1941431,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,8431,NR0B2,https://ctdbase.org/detail.go?type=gene&acc=8431,,,8431.0,NR0B2,9606.0,Homo sapiens (human),Farnesol analog results in decreased expression of NR0B2 mrna|[farnesol analog co-treated with oleic acid] results in decreased expression of NR0B2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
101,1941432,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,9606.0,Homo sapiens (human),Farnesol analog results in decreased expression of NR1H4 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
102,1941433,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,9606.0,Homo sapiens (human),Farnesol binds to and results in increased activity of NR1H4 protein,,,PMID:15491415,https://www.ncbi.nlm.nih.gov/pubmed/15491415,15491415,,
103,1941472,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,47144.0,Tetraodon,Farnesol binds to and results in increased activity of NR1H4 protein|farnesol analog binds to and results in increased activity of NR1H4 protein,,,PMID:21291553,https://www.ncbi.nlm.nih.gov/pubmed/21291553,21291553,,
104,1941473,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,9606.0,Homo sapiens (human),Farnesol analog results in decreased expression of PCK1 mrna|[farnesol analog co-treated with oleic acid] results in increased expression of PCK1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
105,1941474,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,23590,PDSS1,https://ctdbase.org/detail.go?type=gene&acc=23590,,,23590.0,PDSS1,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of PDSS1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
106,1941475,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123.0,PLIN2,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of PLIN2 mrna|farnesol analog results in increased expression of PLIN2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
107,1941476,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of PPARA mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
108,1941477,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),Farnesol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
109,1941478,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of PPARG mrna|farnesol analog results in increased expression of PPARG mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
110,1941479,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10116.0,Rattus norvegicus (Norway rat),Farnesol inhibits the reaction [atorvastatin inhibits the reaction [TNF protein results in decreased expression of PPARGC1A protein]],,,PMID:22343369,https://www.ncbi.nlm.nih.gov/pubmed/22343369,22343369,,
111,1941480,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5875,RABGGTA,https://ctdbase.org/detail.go?type=gene&acc=5875,,,5875.0,RABGGTA,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of RABGGTA mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
112,1941481,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,5876,RABGGTB,https://ctdbase.org/detail.go?type=gene&acc=5876,,,5876.0,RABGGTB,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of RABGGTB mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
113,1941530,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,9606.0,Homo sapiens (human),Farnesol analog inhibits the reaction [EGF protein results in increased activity of RHOA protein]|farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOA protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
114,1941531,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,10116.0,Rattus norvegicus (Norway rat),Farnesol inhibits the reaction [lovastatin affects the localization of RHOA protein],,,PMID:9398081,https://www.ncbi.nlm.nih.gov/pubmed/9398081,9398081,,
115,1941532,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,389,RHOC,https://ctdbase.org/detail.go?type=gene&acc=389,,,389.0,RHOC,9606.0,Homo sapiens (human),Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein],,,PMID:24587105,https://www.ncbi.nlm.nih.gov/pubmed/24587105,24587105,,
116,1941533,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Farnesol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
117,1941534,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,79966,SCD5,https://ctdbase.org/detail.go?type=gene&acc=79966,,,79966.0,SCD5,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in decreased expression of SCD5 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
118,1941535,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,6317,SERPINB3,https://ctdbase.org/detail.go?type=gene&acc=6317,,,6317.0,SERPINB3,9606.0,Homo sapiens (human),Farnesol results in increased expression of SERPINB3 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
119,1941536,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,788,SLC25A20,https://ctdbase.org/detail.go?type=gene&acc=788,,,788.0,SLC25A20,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of SLC25A20 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
120,1941537,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,376497,SLC27A1,https://ctdbase.org/detail.go?type=gene&acc=376497,,,376497.0,SLC27A1,9606.0,Homo sapiens (human),[farnesol analog co-treated with oleic acid] results in increased expression of SLC27A1 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
121,1941538,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,11001,SLC27A2,https://ctdbase.org/detail.go?type=gene&acc=11001,,,11001.0,SLC27A2,9606.0,Homo sapiens (human),Farnesol analog results in increased expression of SLC27A2 mRNA,,,PMID:30611723,https://www.ncbi.nlm.nih.gov/pubmed/30611723,30611723,,
122,1941539,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,23657,SLC7A11,https://ctdbase.org/detail.go?type=gene&acc=23657,,,23657.0,SLC7A11,9606.0,Homo sapiens (human),Farnesol results in increased expression of SLC7A11 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
123,1941580,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Farnesol results in increased expression of TNF mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
124,1941581,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Farnesol inhibits the reaction [atorvastatin inhibits the reaction [TNF protein results in decreased expression of PPARGC1A protein]],,,PMID:22343369,https://www.ncbi.nlm.nih.gov/pubmed/22343369,22343369,,
125,1941582,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,9606.0,Homo sapiens (human),UGT1A1 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
126,1941583,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54659,UGT1A3,https://ctdbase.org/detail.go?type=gene&acc=54659,,,54659.0,UGT1A3,9606.0,Homo sapiens (human),UGT1A3 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
127,1941584,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54657,UGT1A4,https://ctdbase.org/detail.go?type=gene&acc=54657,,,54657.0,UGT1A4,9606.0,Homo sapiens (human),UGT1A4 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
128,1941585,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,9606.0,Homo sapiens (human),UGT1A6 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
129,1941586,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600.0,UGT1A9,9606.0,Homo sapiens (human),UGT1A9 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
130,1941587,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7363,UGT2B4,https://ctdbase.org/detail.go?type=gene&acc=7363,,,7363.0,UGT2B4,9606.0,Homo sapiens (human),UGT2B4 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
131,1941588,445070,Comparative Toxicogenomics Database (CTD),"trans,trans-Farnesol",D005204,Farnesol,https://ctdbase.org/detail.go?type=chem&acc=D005204,7364,UGT2B7,https://ctdbase.org/detail.go?type=gene&acc=7364,,,7364.0,UGT2B7,9606.0,Homo sapiens (human),UGT2B7 protein results in increased glucuronidation of farnesol,,,PMID:15320866,https://www.ncbi.nlm.nih.gov/pubmed/15320866,15320866,,
132,1985013,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,1238,Monoamine oxidase type B (MAO-B) Mutant (I199F),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1238,,,,,,,,Ki (nM),>1000000,PMID:15710600,https://www.ncbi.nlm.nih.gov/pubmed/15710600,15710600,,
133,1985014,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,384,Amine oxidase (flavin-containing) A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=384,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),,Ki (nM),>1000000,PMID:15710600,https://www.ncbi.nlm.nih.gov/pubmed/15710600,15710600,,
134,1985015,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,385,Amine oxidase [flavin-containing] B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=385,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),,Ki (nM),2300,PMID:15710600,https://www.ncbi.nlm.nih.gov/pubmed/15710600,15710600,,
135,1985016,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,50002008,Monoamine Oxidase Type B (MAO-B),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50002008,P56560,Amine oxidase [flavin-containing] B,338445.0,MAOB,9913.0,Bos taurus (cattle),,Ki (nM),>1000000,PMID:15710600,https://www.ncbi.nlm.nih.gov/pubmed/15710600,15710600,,
136,1985027,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,1130,Monoamine Oxidase Type B (MAO-B),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1130,P19643,Amine oxidase [flavin-containing] B,25750.0,Maob,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),5000,PMID:15710600,https://www.ncbi.nlm.nih.gov/pubmed/15710600,15710600,,
137,1985028,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,50001942,Monoamine Oxidase Type B (MAO-B),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=50001942,Q8BW75,Amine oxidase [flavin-containing] B,109731.0,Maob,10090.0,Mus musculus (house mouse),,Ki (nM),2400,PMID:15710600,https://www.ncbi.nlm.nih.gov/pubmed/15710600,15710600,,
138,1985029,445070,BindingDB,"trans,trans-Farnesol",11021,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11021,385,Amine oxidase [flavin-containing] B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=385,P27338,Amine oxidase [flavin-containing] B,4129.0,MAOB,9606.0,Homo sapiens (human),,Ki (nM),800,PMID:15710600,https://www.ncbi.nlm.nih.gov/pubmed/15710600,15710600,,
